Reinier G.S. MeesterAssistant Professor
Research groupEvaluation of screening
I am an Assistant Professor in Public Health with almost 10 years of research experience. My career goal is to improve population health through advanced computational and data-analytic approaches. Common sources of information include demographic, epidemiologic, economic, clinical, and biological data; research methodology draws from decision and data sciences.
A primary research interest is personalized prevention of cancer, with a focus on colorectal cancer, liver cancer, and stomach cancer. For colorectal cancer, our work has informed both national and international screening policy. Recently, I co-initiated a new research line around mental health promotion. The research is conducted in collaboration with diverse clinical and methodological research groups worldwide.
2019 Postdoc. Health systems modeling, Stanford University.
2017 Ph.D. Health sciences, Erasmus University.
2009 M.S. Econometrics, University of Amsterdam.
2007 B.S. Operations research & econometrics, University of Amsterdam.
Primary Investigator. NIH #. Comparative modeling of gastric cancer disparities and prevention in the US and globally.
Co-Investigator. RIVM. National evaluation of colorectal cancer screening.
Co-Investigator. NIH #U01 CA253913. Comparative Modeling of Effective Policies for Colorectal Cancer Control.
Co-Investigator. NIH #R01 CA243449. Optimizing colorectal cancer prevention: a multi-disciplinary, population-based investigation of serrated polyps using risk prediction and modelling.
Most relevant publications
Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration.
Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force.
COVID-19 and cancer.
Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests.
J Natl Cancer Inst
Prevalence and Clinical Features of Sessile Serrated Polyps: A Systematic Review.
High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas: A Cost-Effectiveness Analysis.
Ann Intern Med
Trends in Incidence and Stage at Diagnosis of Colorectal Cancer in Adults Aged 40 Through 49 Years, 1975-2015.
The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline.
Optimizing colorectal cancer screening by race and sex: Microsimulation analysis II to inform the American Cancer Society colorectal cancer screening guideline.